Drug shortages

Enoxaparin Sodium Injection

Sanofi-Aventis U.S. LLC

To Be Discontinued0955-1006-10Hematology
Open FDA's page for this record
Discontinued date
10/20/2026
Update type
New
Initial posting date
10/20/2026
Package NDC
0955-1006-10
Generic name
Enoxaparin Sodium Injection
Contact info
800-631-1610
Update date
10/20/2026
Dosage form
Injection
Presentation
Enoxaparin Sodium, Injection, 60 mg/.6 mL (NDC 0955-1006-10)
Company name
Sanofi-Aventis U.S. LLC
Status
To Be Discontinued
Related info

Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.

Therapeutic category
Hematology
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.